ask="N/A"
ask_size="N/A"
average_daily_volume="195546"
bid="N/A"
bid_size="N/A"
book_value="7.04"
change="-0.30"
change_from_200_day_moving_average="7.79"
change_from_50_day_moving_average="4.59"
change_from_52_week_high="-4.98"
change_From_52_week_low="11.15"
change_in_percent="-1.26%"
close="23.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.97"
eps_estimate_next_year="-3.30"
ex_dividend_date="N/A"
float_shares="18669000"
high="24.30"
high_52_weeks="28.48"
last_trade_date="1/6/2017"
last_trade_price="23.50"
last_trade_size="16430"
last_trade_time="4:00pm"
low="23.30"
low_52_weeks="12.35"
market_capitalization="670.10M"
moving_average_200_day="15.71"
moving_average_50_day="18.91"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="34.60"
open="24.05"
pe_ratio="N/A"
peg_ratio="-0.64"
percent_change_from_200_day_moving_average="+49.59%"
percent_change_from_50_day_moving_average="+24.25%"
percent_change_from_52_week_high="-17.49%"
percent_change_from_52_week_low="+90.28%"
previous_close="23.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.38"
price_per_sales="2262.19"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="27.10"
stock_exchange="NGM"
symbol="RVNC"
volume="306246"
weeks_range_52="12.35 - 28.48"
